See full prescribing information for IRESSA.<br/>IRESSA (gefitinib) tablets for oral use<br/>Initial U.S. Approval: 2015</title>

Gefitinib, sold under the brand name Iressa, is a medication used for certain breast, lung and other cancers. Gefitinib is an EGFR inhibitor, like erlotinib, which interrupts signaling through …

IRESSA is indicated as monotherapy for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of both platinum-based and docetaxel …

Nov 26, 2024 · Iressa is a cancer medication that interferes with the growth and spread of cancer cells in the body. Iressa is used to treat non-small cell lung cancer. Iressa is sometimes used …

Jul 13, 2015 · IRESSA is an oral, EGFR tyrosine kinase inhibitor (TKI), which works by blocking the activity of the EGFR tyrosine kinase enzyme responsible for regulating signalling pathways …

Feb 24, 2025 · IRESSA is a tyrosine kinase inhibitor indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal …

Jun 29, 2022 · Iressa (gefitinib) is a tyrosine kinase inhibitor used for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal …

Find patient medical information for Iressa oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.

Gefitinib is a type of targeted cancer drug. You pronounce it as jeh-fit-ih-nib. It is also known as Iressa. It is a treatment for non small cell lung cancer (NSCLC) that has spread into the …

Feb 16, 2020 · What is Iressa used for? Iressa is used to treat lung cancer. If you are allergic to Iressa; any part of this medicine; or any other drugs, foods, or substances. Tell your doctor …